Longevity Research Panel | NAD+, Epithalon & MOTS-c Multi-Hallmark Aging Research

The Longevity Research Panel brings together NAD+, Epithalon, and MOTS-c into a single multi-hallmark aging research protocol. Each compound targets a different mechanism of biological aging documented in the Lopez-Otin hallmarks of aging framework, allowing researchers to study cellular senescence, telomere maintenance, and mitochondrial dysfunction in parallel within one experimental design.

Longevity Panel (NAD+, Epithalon, MOTS-c): Research Overview

The Longevity Research Panel is a pre-formulated combination of three compounds that address three distinct hallmarks of biological aging. NAD+ targets the coenzyme-level decline associated with sirtuin dysregulation and impaired DNA repair. Epithalon targets the telomere attrition hallmark through telomerase activation in somatic cell models. MOTS-c targets mitochondrial dysfunction via AMPK-driven retrograde signaling from mitochondria to the nucleus.

The combination has been studied across multiple aging biology contexts:

• Sirtuin Pathway Research: NAD+ provides the substrate required for SIRT1 through SIRT7 deacetylase activity, which regulates gene expression, mitochondrial biogenesis, and stress response. Combining with Epithalon and MOTS-c allows researchers to examine sirtuin activity across nuclear, telomeric, and mitochondrial substrates simultaneously.
• Telomere Biology: Epithalon has been investigated for telomerase (hTERT) activation in somatic cell models. The combination with NAD+ enables researchers to study whether sirtuin-mediated DNA damage repair pathways interact with telomerase-mediated telomere maintenance during cellular aging.
• Mitochondrial Function: MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Research has examined its role in AMPK activation, metabolic flexibility, and skeletal muscle function. Pairing with NAD+ creates a research context for studying mitochondrial biology from both metabolic and biogenesis angles.
• Multi-Mechanism Aging Models: The geroscience field has moved beyond single-target interventions. This panel allows simultaneous investigation of biochemical, telomere, and mitochondrial axes in one experimental setup, reducing variables and enabling researchers to examine interaction effects between aging mechanisms.

The individual components are also available as standalone products: NAD+ 750mg, Epithalon 20mg, and MOTS-c. For the full research protocol writeup including synergy rationale and study citations, see the Longevity Research Panel Protocol page.

Research Context: Longevity Panel in the Aging Biology Research Landscape

The geroscience research field has converged on a multi-hallmark framework first formalized by Lopez-Otin and colleagues in their 2013 Cell publication on the hallmarks of aging. The framework identifies nine distinct biological processes that contribute to aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Each compound in this panel addresses a different listed hallmark.

• Longevity Research Panel (NAD+, Epithalon, MOTS-c): Multi-hallmark stack covering sirtuin, telomere, and mitochondrial mechanisms in a single research protocol
• NAD+ 750mg: Standalone; sirtuin substrate, PARP-mediated DNA repair, mitochondrial biogenesis
• Epithalon 20mg: Standalone; telomerase activation, cellular replicative lifespan, pineal-related research
• MOTS-c: Standalone; mitochondrial-derived peptide, AMPK signaling, metabolic flexibility
• GHK-Cu: Adjacent longevity research; collagen synthesis and antioxidant gene transcription

Related Research Resources

• Longevity Peptides: MOTS-c, Epithalon and NAD+ Cellular Aging Research
• Best Peptides for Anti-Aging Research 2026
• What Are Peptides: The Complete 2026 Research Guide
• Peptide Stacking Research Guide: Synergistic Combinations
• How to Reconstitute Peptides Safely for R&D
• Longevity Research Area Hub

Key Properties

• NAD+ (Nicotinamide Adenine Dinucleotide): A coenzyme essential for sirtuin deacetylase activity (SIRT1 through SIRT7), PARP-mediated DNA strand break repair, and CD38-mediated calcium signaling. Cellular NAD+ levels decline with age across multiple tissue types, making restoration a major research target.
• Epithalon: A tetrapeptide developed by the Khavinson group with the sequence Ala-Glu-Asp-Gly. Research has documented telomerase activation in human somatic cell cultures, with effects on telomere length and replicative lifespan in fibroblast and other somatic cell populations.
• MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c): A 16-amino-acid peptide encoded within the mitochondrial genome and discovered by Lee et al. in 2015. Research has characterized its role in AMPK activation, metabolic homeostasis, and inter-tissue signaling from mitochondria to nuclei.
• Combined Research Applications: The three compounds operate on non-overlapping mechanisms. NAD+ enables sirtuin activity, MOTS-c activates AMPK downstream of mitochondria, and Epithalon operates at the telomere level. Combination studies can examine whether modulating one axis influences another.

Applications in Research

The Longevity Research Panel supports laboratory studies in:

• Multi-hallmark aging biology research designs targeting multiple mechanisms simultaneously.
• Sirtuin substrate availability and downstream effects on gene expression and stress response.
• Telomerase activation and replicative lifespan in somatic cell culture models.
• Mitochondrial retrograde signaling, AMPK activation, and metabolic flexibility research.
• Interaction effects between coenzyme-level, telomere-level, and mitochondrial mechanisms.

All studies are conducted in controlled laboratory settings.

Storage and Handling Instructions

• Store NAD+, Epithalon, and MOTS-c in lyophilized form at 42°F (5°C) or lower, with long-term storage at -20°C or below.
• Protect from light, moisture, and excessive heat to preserve compound stability and assay reliability.
• Reconstitute each component separately with sterile bacteriostatic water according to the research protocol.
• Use post-reconstitution solutions promptly and discard following institutional research protocols.

Safety Information

This product is intended for in vitro research purposes only. Laboratory personnel must:

• Follow institutional biosafety guidelines for handling and storage of research peptides.
• Use appropriate personal protective equipment during reconstitution and experimental work.
• Document all experimental protocols according to institutional review requirements.

Frequently Asked Questions

Why are three different longevity compounds included rather than selecting one?

Biological aging is driven by multiple parallel mechanisms, not a single root cause. NAD+ addresses coenzyme-level decline and sirtuin activity, Epithalon addresses telomere shortening, and MOTS-c addresses mitochondrial metabolic signaling. Studying all three together allows researchers to examine whether interventions at each level are additive, synergistic, or independent. Single-target approaches cannot capture interactions between aging mechanisms, which is a central question in modern geroscience.

Which compound in the panel has the longest research history?

NAD+ has by far the longest research history. It is a fundamental coenzyme that has been studied in cellular biochemistry for over a century, with sirtuin-related NAD+ research expanding substantially in the 1990s and 2000s. Epithalon was developed by the Khavinson group in the 1980s and 1990s. MOTS-c is the most recently identified of the three, with its discovery published by Lee et al. in Cell Metabolism in 2015. The panel combines a foundational biochemical target, a long-studied tetrapeptide, and a recently characterized mitochondrial signaling molecule.

Is there published research combining NAD+ with Epithalon or MOTS-c?

Direct combination studies in the published literature are limited. Most published research examines each compound in isolation. The mechanistic rationale for combining them is well-supported by the established biology: NAD+ and MOTS-c both converge on mitochondrial function from different directions, and Epithalon adds the telomere dimension that neither of the others addresses. Researchers designing combination protocols typically rely on this mechanistic complementarity in the absence of direct combination trial data.

How does this panel differ from the Skin and Collagen Research Protocol?

The Longevity Research Panel targets systemic cellular aging biology through sirtuin, telomere, and mitochondrial mechanisms relevant to multiple tissue types. The Skin and Collagen Research Protocol uses GHK-Cu and Epithalon to focus specifically on dermal tissue, combining matrix-level effects (collagen synthesis, MMP modulation) with cellular longevity (telomerase activation in fibroblasts). The two protocols share Epithalon but address different research questions.

What purity standards are required for research-grade NAD+, Epithalon, and MOTS-c?

All three research compounds should demonstrate at least 98% purity as verified by HPLC analysis, with molecular identity confirmed by mass spectrometry. In-house purity testing ensures batch consistency. Researchers should verify purity documentation and batch-specific data before initiating any experimental protocol.

Are the three compounds reconstituted together or separately?

Each compound should be reconstituted separately with sterile bacteriostatic water according to its individual protocol. Reconstituting the components separately preserves the integrity of each peptide and allows researchers to maintain independent dosing control across the three mechanisms during experimental design.

References

1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. "The hallmarks of aging." Cell. 2013;153(6):1194-1217. PubMed: 23746838
2. Lee C, Zeng J, Drew BG, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metab. 2015;21(3):443-454. PubMed: 25738459
3. Khavinson VK, Bondarev IE, Butyugov AA. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bull Exp Biol Med. 2003;135(6):590-592. PubMed: 12937682
4. Imai S, Guarente L. "NAD+ and sirtuins in aging and disease." Trends Cell Biol. 2014;24(8):464-471. PubMed: 24786309
5. Anisimov VN, Khavinson VK. "Peptide bioregulation of aging: results and prospects." Biogerontology. 2010;11(2):139-149. PubMed: 19543815
6. Verdin E. "NAD+ in aging, metabolism, and neurodegeneration." Science. 2015;350(6265):1208-1213. PubMed: 26785480
7. Kim KH, Son JM, Benayoun BA, Lee C. "The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress." Cell Metab. 2018;28(3):516-524.e7. PubMed: 29983246